Evaluating how different medications in the same class can be safely exchanged for older adults.
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications
['FUNDING_R01'] · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · NIH-10818597
This study is looking at how safe and effective different medications for chronic conditions are for older adults, using real-life data from Medicare to see if some drugs are better or riskier than others, so doctors can make smarter choices when prescribing.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUTGERS BIOMEDICAL AND HEALTH SCIENCES (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-10818597 on ClinicalTrials.gov |
What this research studies
This research investigates the effectiveness and safety of medications within the same class, particularly focusing on older adults who often face chronic conditions. It aims to address the lack of data from head-to-head trials by utilizing the structure of Medicare Part D, which creates natural experiments based on varying out-of-pocket costs for different drugs. By analyzing these financial incentives, the study seeks to determine whether certain medications are truly interchangeable or if some may pose greater risks than others. This approach could lead to more informed prescribing practices and better patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who are prescribed medications within the same therapeutic class, particularly those with chronic conditions.
Not a fit: Patients who are not taking medications within the same class or who are younger and not affected by chronic conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medication choices for older adults, reducing the risk of adverse clinical outcomes.
How similar studies have performed: While the concept of therapeutic exchangeability has been acknowledged, this specific approach using Medicare Part D as a natural experiment is relatively novel and has not been extensively tested.
Where this research is happening
Newark, UNITED STATES
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GERHARD, TOBIAS — RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- Study coordinator: GERHARD, TOBIAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.